REFERENCES
1. Mankad P, Mitchell B, Birnie D, Kron J. Cardiac Sarcoidosis.Curr Cardiol Rep . 2019;21(12):152. doi:10.1007/s11886-019-1238-1.
2. Vignaux O, Dhote R, Duboc D, Blanche P, Devaux JY, Weber S, Legmann
P. Detection of myocardial involvement in patients with sarcoidosis
applying T2-weighted, contrast-enhanced, and cine magnetic resonance
imaging: Initial results of a prospective study. J Comput Assist
Tomogr . 2002;26(5):762-767. doi:10.1097/00004728-200209000-00017.
3. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: A
clinicopathologic study of 84 unselected patients with systemic
sarcoidosis. Circulation . 1978;58(6):1204-1211.
doi:10.1161/01.CIR.58.6.1204.
4. Ramirez R, Trivieri M, Fayad ZA, Ahmadi A, Narula J, Argulian E.
Advanced imaging in cardiac sarcoidosis. J Nucl Med .
2019;60(7):892-898. doi:10.2967/jnumed.119.228130.
5. Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS,
Judson MA, Kron J, Mehta D, Cosedis Nielsen J, Patel AR, Ohe T,
Raatikainen P, Soejima K. HRS expert consensus statement on the
diagnosis and management of arrhythmias associated with cardiac
sarcoidosis. Heart Rhythm . 2014;11(7):1304-1323.
doi:10.1016/j.hrthm.2014.03.043.
6. Morimoto T, Azuma A, Abe S, Usuki J, Kudoh S, Sugisaki K, Oritsu M,
Nukiwa T. Epidemiology of sarcoidosis in Japan. Eur Respir J .
2008;31(2):372-379. doi:10.1183/09031936.00075307.
7. Sharma A, Okada DR, Yacoub H, Chrispin J, Bokhari S. Diagnosis of
cardiac sarcoidosis: an era of paradigm shift. Ann Nucl Med .
2020;34(2):87-93. doi:10.1007/s12149-019-01431-z.
8. Neto MLR, Jellis CL, Joyce E, Callahan TD, Hachamovitch R, Culver DA.
Update in Cardiac Sarcoidosis. Ann Am Thorac Soc .
2019;16(11):1341-1350. doi:10.1513/AnnalsATS.201902-119CME.
9. Kouranos V, Tzelepis GE, Rapti A, Mavrogeni S, Aggeli K, Douskou M,
Prasad S, Koulouris N, Sfikakis P, Wells A, Gialafos E. Complementary
Role of CMR to Conventional Screening in the Diagnosis and Prognosis of
Cardiac Sarcoidosis. JACC Cardiovasc Imaging .
2017;10(12):1437-1447. doi:10.1016/j.jcmg.2016.11.019.
10. Schouver ED, Moceri P, Doyen D, Tieulie N, Queyrel V, Baudouy D,
Cerboni P, Gibelin P, Leroy S, Fuzibet JG, Ferrari E. Early detection of
cardiac involvement in sarcoidosis with 2-dimensional speckle-tracking
echocardiography. Int J Cardiol . 2017;227:711-716.
doi:10.1016/j.ijcard.2016.10.073.
11. Voigt JU, Pedrizzetti G, Lysyansky P, Marwick TH, Houle H, Baumann
R, Pedri S, Ito Y, Abe Y, Metz S, Song JH, Hamilton J, Sengupta PP,
Kolias TJ, D’Hooge J, Aurigemma GP, Thomas JD, Badano LP. Definitions
for a common standard for 2D speckle tracking echocardiography:
Consensus document of the EACVI/ASE/industry task force to standardize
deformation imaging. J Am Soc Echocardiogr . 2015;28(2):183-193.
doi:10.1016/j.echo.2014.11.003.
12. Moharram MA, Lamberts RR, Whalley G, Williams MJA, Coffey S.
Myocardial tissue characterisation using echocardiographic deformation
imaging. Cardiovasc Ultrasound . 2019;17(1).
doi:10.1186/s12947-019-0176-9.
13. Moher D, Liberati A, Tetzlaff J, Altman DG, Group TP. Preferred
Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA
Statement. PLoS Med . 2009;6(7):e1000097.
doi:10.1371/journal.pmed.1000097.
14. Lo CKL, Mertz D, Loeb M. Newcastle-Ottawa Scale: Comparing
reviewers’ to authors’ assessments. BMC Med Res Methodol .
2014;14(1):45. doi:10.1186/1471-2288-14-45.
15. Aggeli C, Felekos I, Tousoulis D, Gialafos E, Rapti A, Stefanadis C.
Myocardial mechanics for the early detection of cardiac sarcoidosis.Int J Cardiol . 2013;168(5):4820-4821.
doi:10.1016/j.ijcard.2013.07.010.
16. Tigen K, Sunbul M, Karaahmet T, Tasar O, Dundar C, Yalcinsoy M,
Takir M, Akkaya E. Early Detection of Bi-ventricular and Atrial
Mechanical Dysfunction Using Two-Dimensional Speckle Tracking
Echocardiography in Patients with Sarcoidosis. Lung .
2015;193(5):669-675. doi:10.1007/s00408-015-9748-0.
17. Kul S, Ozcelik HK, Uyarel H, Karakus G, Guvenc TS, Yalcinsoy M,
Asoglu E, Kemik AS, Tasal A, Gungor S, Karaarslan E, Kart L, Goktekin O.
Diagnostic value of strain echocardiography, galectin-3, and tenascin-C
levels for the identification of patients with pulmonary and cardiac
sarcoidosis. Lung . 2014;192(4):533-542.
doi:10.1007/s00408-014-9586-5.
18. Kusunose K, Fujiwara M, Yamada H, Nishio S, Saijo Y, Yamada N,
Hirata Y, Torii Y, Ise T, Yamaguchi K, Fukuda D, Yagi S, Soeki T,
Wakatsuki T, Sata M. Deterioration of biventricular strain is an early
marker of cardiac involvement in confirmed sarcoidosis. Eur Hear J
- Cardiovasc Imaging . 2019;81:1-9. doi:10.1093/ehjci/jez235.
19. Bayat F, Fahimi A, Tavana S, Tabary M, Khaheshi I. Subclinical
involvement of the heart and its associated factors in patients with
sarcoidosis with normal systolic function using 2D speckle tracking.Echocardiography . 2020;37(1):41-46. doi:10.1111/echo.14572.
20. Joyce E, Ninaber MK, Katsanos S, Debonnaire P, Kamperidis V, Bax JJ,
Taube C, Delgado V, Marsan NA. Subclinical left ventricular dysfunction
by echocardiographic speckle-tracking strain analysis relates to outcome
in sarcoidosis. Eur J Heart Fail . 2015;17(1):51-62.
doi:10.1002/ejhf.205.
21. Felekos I, Aggeli C, Gialafos E, Kouranos V, Rapti A, Sfikakis P,
Koulouris N, Tousoulis D. Global longitudinal strain and long-term
outcomes in asymptomatic extracardiac sarcoid patients with no apparent
cardiovascular disease. Echocardiography . 2018;35(6):804-808.
doi:10.1111/echo.13846.
22. Değirmenci H, Demirelli S, Arısoy A, Ermiş E, Araz Ö, Bakırcı EM,
Hamur H, Büyüklü M, Topal E. Myocardial deformation and total atrial
conduction time in the prediction of cardiac involvement in patients
with pulmonary sarcoidosis. Clin Respir J . 2017;11(1):68-77.
doi:10.1111/crj.12307.
23. Murtagh G, Laffin LJ, Patel K V., Patel A V., Bonham CA, Yu Z,
Addetia K, El-Hangouche N, Maffesanti F, Mor-Avi V, Hogarth DK, Sweiss
NJ, Beshai JF, Lang RM, Patel AR. Improved detection of myocardial
damage in sarcoidosis using longitudinal strain in patients with
preserved left ventricular ejection fraction. Echocardiography .
2016;33(9):1344-1352. doi:10.1111/echo.13281.
24. Chiu CZ, Nakatani S, Zhang G, Tachibana T, Ohmori F, Yamagishi M,
Kitakaze M, Tomoike H, Miyatake K. Prevention of left ventricular
remodeling by long-term corticosteroid therapy in patients with cardiac
sarcoidosis. Am J Cardiol . 2005;95(1):143-146.
doi:10.1016/j.amjcard.2004.08.083.
25. Sengupta PP, Korinek J, Belohlavek M, Narula J, Vannan MA, Jahangir
A, Khandheria BK. Left Ventricular Structure and Function. Basic Science
for Cardiac Imaging. J Am Coll Cardiol . 2006;48(10):1988-2001.
doi:10.1016/j.jacc.2006.08.030.
26. MM K, PM P, H A, G C, S W, AJ T, BK K, PP S. Relationship of
Contrast-Enhanced Magnetic Resonance Imaging-Derived Intramural Scar
Distribution and Speckle Tracking Echocardiography-Derived Left
Ventricular Two-Dimensional Strains. Eur Heart J Cardiovasc
Imaging . 2012;13(2). doi:10.1093/EJECHOCARD/JER163.
27. Orii M, Hirata K, Tanimoto T, Shiono Y, Shimamura K, Yamano T, Ino
Y, Yamaguchi T, Kubo T, Tanaka A, Imanishi T, Akasaka T. Myocardial
damage detected by two-dimensional speckle-tracking echocardiography in
patients with extracardiac sarcoidosis: Comparison with magnetic
resonance imaging. J Am Soc Echocardiogr . 2015;28(6):683-691.
doi:10.1016/j.echo.2015.02.018.
28. Kim RJ, Patel MR, Cawley PJ, Heitner JF, Klem I, Parker MA, Jaroudi
WA, Meine TJ, White JB, Elliott MD, Kim HW, Judd RM. Detection of
myocardial damage in patients with sarcoidosis. Circulation .
2009;120(20):1969-1977. doi:10.1161/CIRCULATIONAHA.109.851352.
29. Chen, J., Lei, J., Scalzetti, E., McGrath, M., Feiglin, D., Voelker,
R., Wang, J., Iannuzzi, M. C., & Liu, K. (2018). Myocardial contractile
patterns predict future cardiac events in sarcoidosis. The international
journal of cardiovascular imaging, 34(2), 251–262.
https://doi.org/10.1007/s10554-017-1233-9